AstraZeneca Eliminating 1,800 R&D Jobs in Delaware

AstraZeneca PLC is eliminating 1,800 research and development jobs as part of a restructuring process. The pharmaceutical company said about 550 jobs will be eliminated at its U.S. headquarters in Delaware, where it psychiatric research laboratory will be closed.

AstraZeneca will also be closing research sites in Sweden and the United Kingdom, the Associated Press reports. Overall, AstraZeneca plans to cut 8,000 more jobs, or 12 percent of its workforce by 2014. Its research and development efforts will now be focused getting drugs through clinical trials and regulatory approval.

Career Connect (From our other career blogs):

Employment News (Sponsored by EmploymentSpectator)
Following Your Passion-Literally! (Sponsored by iamnotastalker.com)
Job Search Advice from the CEO of TravelingCrossing (Sponsored by aharrisonbarnes.com)
Layoff News (Sponsored by LayOffWatch)

Testimonial of the Week

I was very pleased with the TravelingCrossing. I found a great position within a short amount of time … I definitely recommend this to anyone looking for a better opportunity.

Jose M Santa Cruz, CA

+ Read More Testimonial

Only TravelingCrossing consolidates every job it can find in the domain and puts all of the job listings it locates in one place.

We have more jobs than any other job board.
We list jobs you will not find elsewhere that are hidden in small regional publications and employer websites
We collect jobs from more than 4,429,376 websites and post them on our site.
We are private, and therefore far fewer people are applying for the jobs on our site than are applying for those on public job boards.